Back to Stress
SupplementPreliminary evidenceStress

L-tyrosine

Catecholamine precursor with RCT signal for cognitive performance under acute stress (cold, sleep deprivation, high cognitive load).

Why

L-tyrosine is the precursor for dopamine, noradrenaline and adrenaline, produced from phenylalanine. Multiple small military and laboratory RCTs report cognitive-performance preservation under acutely-stressful conditions (cold exposure, sleep deprivation, multitasking) at 100–300 mg/kg single doses. Less effective in non-stressed adults, the effect is most consistent when catecholamine demand is elevated.

How it works

Provides substrate for tyrosine hydroxylase, the rate-limiting enzyme in catecholamine synthesis. Under acute stress, catecholamine release rates can exceed dietary substrate availability, transiently depleting catecholamines, tyrosine supplementation rescues this.

Expected onset · Acute effect within 60–90 minutes

How to take

Dosage

Acute stress: 100–300 mg/kg as single dose 60 min before stressor (~7–22 g for a 75 kg adult). Lower daily-use doses: 500–2,000 mg.

Timing

60 minutes before anticipated stress; on empty stomach for absorption

On the label

'L-tyrosine' or 'N-acetyl-L-tyrosine' (NALT), NALT claims better solubility but has weaker evidence base. Stated grams per dose.

Ideal for

Adults with anticipated acute cognitive stress (high-stakes presentation, exam, military or first-responder scenario, sustained high cognitive load); not for chronic supplementation.

Safety

Avoid with MAOIs (catecholamine accumulation, hypertensive crisis). Caution with thyroid medications (tyrosine is thyroid hormone precursor), may potentiate. Avoid in hyperthyroidism, melanoma (theoretical), Parkinson disease on L-dopa (additive). Mild headache, nausea possible. Pregnancy data limited.

Evidence

At a glance

Jongkees 2015 systematic review: tyrosine consistently improved cognitive performance under stress (cold exposure, sleep deprivation, high cognitive load), with minimal effect in non-stressed conditions. Preliminary, RCTs exist in non-tier-1 journals but are small or short-duration. No Cochrane review, EMA monograph or EFSA-authorised claim covers the indication. Acute, situation-specific use is the well-defined niche.

Limitations

Preliminary, RCTs exist in non-tier-1 journals but are small or short-duration. No Cochrane review, EMA monograph or EFSA-authorised claim covers the indication.

Where to get it

Shop L-tyrosine on Amazon

Sponsored · As an Amazon Associate, Healicus earns from qualifying purchases.